Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review

View ORCID ProfileS Gupta, J Parker, S Smits, J Underwood, S Dolwani
doi: https://doi.org/10.1101/2020.04.17.20069526
S Gupta
1Division of Population Medicine, Cardiff University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S Gupta
J Parker
1Division of Population Medicine, Cardiff University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Smits
1Division of Population Medicine, Cardiff University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Underwood
2Division of Infection and Immunity, Department of Infectious Diseases, Cardiff University and Cardiff and Vale University Health Board
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Dolwani
1Division of Population Medicine, Cardiff University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: DolwaniS@cardiff.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Aim In addition to respiratory symptoms, patients with COVID-19 can present with gastrointestinal complaints suggesting a possible faeco-oral transmission route. The primary aim of this review is to establish the incidence and timing of positive faecal samples for the SARS-CoV-2 virus in patients with COVID-19.

Methods A systematic literature review was performed to identify studies describing COVID-19 patients tested for the virus in their stool. Data were extracted concerning the nature of the test, number and timing of positive samples, incidence of positive faecal tests after negative nasopharyngeal swabs and any evidence of viable faecal virus or faeco-oral transmission of the virus.

Results There were 26 relevant articles identified. Combining these results demonstrated that 53·9% of those tested for faecal RNA in these studies were positive. Duration of faecal viral shedding ranged from 1 to 33 days after nasopharyngeal swab turned negative with one result remaining positive after 47 days of onset of symptoms. There was insufficient evidence to draw firm conclusions about the proportion of cases potentially transmitted through infection via faecally shed virus.

Conclusion There is a relatively high rate of positive tests and persistence of the SARS-CoV-2 virus in faecal samples of selected patients with COVID-19. Further research is needed to demonstrate how much these positive tests correlate with viable virus and transmission through the faeco-oral route. This may have important implications for duration of isolation, precautions recommended in individuals undertaking a period of isolation, protective equipment for health professionals and interventional procedures involving the gastrointestinal tract.

What does this paper add to the existing literature?We synthesise all available evidence from multiple sources and clarify the uncertainty around faecal shedding of SARS-CoV-2 virus, its persistence and duration from onset of symptoms, and after negative nasopharyngeal swabs. Evidence for faeco-oral transmission is plausible and demonstrated in one study though its relative contribution to transmission remains unclear.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

S Gupta is funded by the Wales Cancer Research Centre and Cardiff University J Parker is funded by a Royal College of Surgeons of England Research Fellowship S Smits is funded by Health and Care Research Wales health fellowship (ref HF-17-1352) J Underwood is funded by Medical Research Council (Grant Ref: MR/T023791/1) S Dolwani is Chief Investigator of the CONSCOP2 study funded by the NIHR (HTA Project: NIHR127914) There was no payment or services received from a third party by any of the authors or institutions for any aspect of the submitted work.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† Joint First Authors

  • Sources of funding S Gupta is funded by the Wales Cancer Research Centre and Cardiff University

    J Parker is funded by a Royal College of Surgeons of England Research Fellowship

    S Smits is funded by Health and Care Research Wales health fellowship (ref HF-17-1352)

    J Underwood is funded by Medical Research Council (Grant Ref: MR/T023791/1)

    S Dolwani is Chief Investigator of the CONSCOP2 study funded by the NIHR (HTA Project: NIHR127914)

  • Conflicts of interest None declared

Data Availability

This is a systematic review and all the data analyzed was from the studies included in the review which have been cited in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 24, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review
S Gupta, J Parker, S Smits, J Underwood, S Dolwani
medRxiv 2020.04.17.20069526; doi: https://doi.org/10.1101/2020.04.17.20069526
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review
S Gupta, J Parker, S Smits, J Underwood, S Dolwani
medRxiv 2020.04.17.20069526; doi: https://doi.org/10.1101/2020.04.17.20069526

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1091)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9747)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11620)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (622)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)